Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 101
Filtrer
1.
J Appl Microbiol ; 122(4): 900-910, 2017 Apr.
Article de Anglais | MEDLINE | ID: mdl-28055127

RÉSUMÉ

AIMS: The aim of this work was to evaluate the efficacy and safety of Lippia origanoides essential oil as a preservative in industrial products. METHODS AND RESULTS: The composition, antimicrobial activity, mutagenic and toxic potential of L. origanoides were determined. Then, the effect of essential oil as a preservative in food, cosmetics and pharmaceutical products was evaluated. The essential oil of L. origanoides consisted mainly of oxygenated monoterpenes (38·13%); 26·28% corresponded to the compound carvacrol. At concentrations ranging from 0·312 to 1·25 µl ml-1 and in association with polysorbate 80, the essential oil of L. origanoides inhibited the growth of all the tested micro-organisms. The medium lethal dose in mice was 3·5 g kg-1 , which categorizes it as nontoxic according to the European Union criteria, and negative results in the Ames test indicated that this oil was not mutagenic. In combination with polysorbate 80, the essential oil exerted preservative action on orange juice, cosmetic and pharmaceutical compositions, especially in the case of aqueous-based products. CONCLUSIONS: Lippia origanoides essential oil is an effective and safe preservative for orange juice, pharmaceutical and cosmetic products. SIGNIFICANCE AND IMPACT OF THE STUDY: This study allowed for the complete understanding of the antimicrobial action and toxicological potential of L. origanoides essential oil. These results facilitate the development of a preservative system based on L. origanoides essential oil.


Sujet(s)
Cosmétiques , Conservateurs alimentaires/pharmacologie , Lippia/composition chimique , Huile essentielle/pharmacologie , Conservateurs pharmaceutiques/pharmacologie , Animaux , Anti-infectieux/composition chimique , Anti-infectieux/pharmacologie , Cymènes , Conservateurs alimentaires/composition chimique , Conservateurs alimentaires/toxicité , Souris , Monoterpènes/composition chimique , Huile essentielle/composition chimique , Huile essentielle/toxicité , Excipients pharmaceutiques/composition chimique , Excipients pharmaceutiques/pharmacologie , Excipients pharmaceutiques/toxicité , Huiles végétales/composition chimique , Huiles végétales/pharmacologie , Huiles végétales/toxicité , Conservateurs pharmaceutiques/composition chimique , Conservateurs pharmaceutiques/toxicité
2.
Int J Tuberc Lung Dis ; 13(7): 848-54, 2009 Jul.
Article de Anglais | MEDLINE | ID: mdl-19555534

RÉSUMÉ

SETTING: Two sample panels: 1) 20 pulmonary tuberculosis (PTB) patients and 10 healthy subjects from a country with a low incidence of TB (Italy); and 2) 47 PTB patients and 26 healthy subjects from a country with a high incidence of TB (Morocco). OBJECTIVE: To identify a combination of Mycobacterium tuberculosis peptides useful for the serodiagnosis of active PTB. METHODS: Fifty-seven B-cell epitope peptides of M. tuberculosis were evaluated by immunoenzymatic assay and the data were analysed using logistic regression analysis and the random forest method. RESULTS: The best discriminating peptide between PTB patients and healthy subjects from the sample of the low TB incidence country was the 23 amino acid peptide of the Rv3878 protein. The sensitivity and specificity were respectively 65% and 100%. The same peptide had a sensitivity and specificity of respectively 47% and 100% for the sample from the high TB incidence country. The best combination of peptides was a pool of nine peptides which had a sensitivity of 70.2% and a specificity of 100% in the high TB incidence country. CONCLUSIONS: The 9-peptide pool can be useful in identifying patients with active PTB.


Sujet(s)
Antigènes bactériens/sang , Déterminants antigéniques des lymphocytes B , Tuberculose pulmonaire/diagnostic , Antigènes bactériens/immunologie , Études cas-témoins , Test ELISA , Déterminants antigéniques des lymphocytes B/sang , Déterminants antigéniques des lymphocytes B/immunologie , Humains , Incidence , Italie/épidémiologie , Modèles logistiques , Courbe ROC , Sensibilité et spécificité , Tests sérologiques , Tuberculose pulmonaire/épidémiologie , Tuberculose pulmonaire/immunologie
3.
Dig Liver Dis ; 41(4): 263-8, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-18801710

RÉSUMÉ

BACKGROUND AND STUDY AIMS: Among benign oesophageal lesions, caustic strictures are the most difficult to dilate. In low-income countries, children suffering caustic oesophageal injury are frequently referred to the hospitals late, sometimes weeks after ingestion. Therefore, dilatation may be performed late and in highly fibrotic strictures. Reports about endoscopic and clinical outcome of such delayed dilatations are scanty. The aim of this study was to evaluate the safety and efficacy of late caustic stricture dilatations in children, comparing it with the results of timely dilatations, both performed at the Hospital of the Italian Non-Governmental Organization "Emergency" at Goderich, Sierra Leone. PATIENTS AND METHODS: From December 2005 to May 2007, 78 children (<15 years) complaining alkaline caustic ingestion were submitted to oesophageal dilatation, mainly (97%) using Savary dilators. Two groups were identified: children (group 1) with a late treatment (>6 weeks, 37+/-12 weeks), having arrived to the hospital late after ingestion, and children (group 2) dilated timely, i.e. at <6 weeks (4+/-1.4 weeks) after injury. RESULTS: Strictures were severe in all patients. Twenty-five children were dilated late after injury (6.4 dilatations/patient) with a follow-up of 11+/-2.5 months. A successful clinical outcome was observed in 91.6%. Four perforations (2.6% procedure-related) and one death (4.0%) were observed. Strictures recurred once in 72% of patients, twice in 31.8%. Thirty-one children were dilated timely (4.5 dilatations/patient) with a follow-up of 10+/-2.1 months and a clinical success rate of 96.7%. Procedure-related perforation rate was 0.7% with one death (3.2%). Stricture recurred once in 30% and twice in 3.3%. CONCLUSIONS: Delayed dilatation of caustic oesophageal strictures in children carries a higher risk of perforation and a higher recurrence rate.


Sujet(s)
Brûlures chimiques/chirurgie , Dilatation/effets indésirables , Dilatation/méthodes , Sténose de l'oesophage/étiologie , Sténose de l'oesophage/chirurgie , Brûlures chimiques/diagnostic , Enfant , Enfant d'âge préscolaire , Dilatation/mortalité , Perforation de l'oesophage/étiologie , Sténose de l'oesophage/diagnostic , Oesophagoscopie/effets indésirables , Oesophagoscopie/méthodes , Oesophagoscopie/mortalité , Études de suivi , Gastrostomie/effets indésirables , Gastrostomie/méthodes , Gastrostomie/mortalité , Humains , Indice de gravité de la maladie , Facteurs temps , Résultat thérapeutique
4.
Sarcoidosis Vasc Diffuse Lung Dis ; 25(1): 21-8, 2008 Sep.
Article de Anglais | MEDLINE | ID: mdl-19070257

RÉSUMÉ

HLA-DR allelic variants have been associated with tuberculosis (TB) susceptibility in different populations with risk ratios of 3.7 to 7.2. We hypothesized that the genetic susceptibility to TB depends upon the reduced capability of HLA-class II alleles of TB patients to bind and select peptide antigen from the Mycobacterium tuberculosis (MTB) expressed genome. To test this hypothesis, we developed a software that can predict HLA-DR restricted epitopes within the whole MTB genome based on quantitative peptide binding matrices. We analyzed the number of MTB epitopes recognized in two previously described populations of TB patients and matched controls and in a control population comprised of individuals affected by a sarcoid-like granuloma induced by beryllium and by healthy exposed controls. The number of putative epitopes within the whole MTB genome which could be bound by any HLA-DR allele (HLA-DR immunome of MTB) was 405,422 out of 1,304,277 possible 9-mers i.e., 31.08% of the global capability, instead of the expected 35%. When tested at an affinity level equivalent of the 1% of the best binder peptides, the HLA-DR alleles (HLA-DRB1*0801, *0802, *1401, *1501 and *1502) associated with TB susceptibility recognized a significantly lower mean number of MTB-epitopes (7,862 +/- 4,258) than the MTB-epitopes recognized by HLA-DR alleles (HLA-DRB1*0301, *0701, *1101, *1102, *1301 and *1302) negatively associated with TB (11,376 +/- 1,984, p<0.032). The number of epitopes bound at high affinity out of the whole MTB genome by the combination of the two HLA-DR alleles carried by each individual was lower in TB patients [TB-population 1: 11,341 +/- 908 (mean+SEM); TB-population 2: 15,303 +/- 657] than in matched healthy controls (CTR-population 1: 13,587 +/- 605, p<0.03 vs TB-population 1; CTR-population 2: 1,6841 +/- 555, p<0.04 vs TB-population 2). No difference was seen in individuals with the sarcoid-like granuloma induced by beryllium compared to the exposed healthy (beryllium-hypersensitivity: 17,593 +/- 447; controls 18,014 +/- 421; p=0.57). The data suggest that HLA-DR alleles associated with susceptibility to tuberculosis may be endowed with a reduced capability to bind at high affinity T-cell epitopes and select them for antigen presentation. The same alleles may contribute to determine the reaction to mycobacteria in non tuberculous granulomatous disorders.


Sujet(s)
ADN bactérien/génétique , Épitopes/génétique , Prédisposition génétique à une maladie , Génome bactérien , Antigènes HLA-DR/génétique , Mycobacterium tuberculosis/génétique , Tuberculose/génétique , Allèles , Antigènes HLA-DR/immunologie , Chaines HLA-DRB1 , Humains , Mycobacterium tuberculosis/immunologie , Phénotype , Lymphocytes T/immunologie , Tuberculose/microbiologie
5.
Sarcoidosis Vasc Diffuse Lung Dis ; 25(2): 100-16, 2008 Dec.
Article de Anglais | MEDLINE | ID: mdl-19382529

RÉSUMÉ

Sarcoidosis is a systemic granulomatosis disease of unknown origin where a number of microbes, in particular M. tuberculosis and non-tuberculous mycobacteria, have been hypothesized to play a role in disease pathogenesis, possibly through bacterial antigen-driven hypersensitivity. To test this concept, we used bioinformatic tools allowing the identification of antigenic peptides in whole microbial genomes to analyze the interaction between the expressed HLA-DR gene allelic variants and the HLA-DR immunome of all pathogenic bacteria in a population of 149 sarcoidosis affected subjects and 447 controls, all HLA-typed at high resolution. We show here that patients with the Löfgren's syndrome, express HLA-DR alleles that recognize in silico a significantly higher number of bacterial antigen epitopes compared to the control population (18,496+9,114 vs 17,954+8,742; p<0.00001), and the chronic sarcoidosis affected population (17,954+8,742; p<0.00001 vs Löfgren's and controls). Further, the analysis of the ability of the HLA-DR allele combinations expressed by the Löfgren's and the chronic sarcoidosis affected subjects to recognize M. avium epitopes demonstrates that a significantly larger number of Löfgren's are capable of top affinity recognition, compared to chronic sarcoidosis (45% vs 17%, p<0.0037). Finally, both Löfgren's and chronic sarcoidosis subjects expressed HLA-DR allele combinations capable of M. tuberculosis and M. avium epitope recognition at higher affinity than tuberculosis affected subjects (p<0.01 all comparisons). In conclusion, we propose that - at least in a subgroup of affected subjects - sarcoidosis might be part of a spectrum of granulomatous responses to several agents where the Löfgren's syndrome represents the hyper-reactive end of the spectrum while pulmonary tuberculosis and atypical mycobacterial infections might represent the opposite end.


Sujet(s)
Régulation de l'expression des gènes , Prédisposition génétique à une maladie , Antigènes HLA-DR/génétique , Mycobacterium avium/génétique , Sarcoïdose/génétique , Allèles , Sites de fixation des anticorps/génétique , Antigènes HLA-DR/biosynthèse , Chaines HLA-DRB1 , Humains , Mycobacterium avium/immunologie , Mycobacterium avium/métabolisme , Phénotype , Sarcoïdose/immunologie , Sarcoïdose/métabolisme
6.
Minerva Endocrinol ; 32(4): 275-95, 2007 Dec.
Article de Anglais | MEDLINE | ID: mdl-18091664

RÉSUMÉ

Osteoporosis and fractures associated with it constitute a real and serious socio-medical problem, which only recently has come to the forefront of social consciousness. The authors are carrying out a critical re-examination of the medical literature of osteoporosis pharmacological treatment. Particular attention has been paid to studies which show a clear reduction of the primary endpoint that, in the case of this pathology, consists of a reduction of the fracturing event. According to the examination of the clinical studies introduced, antiresorptive bone agents, such as alendronate and risenderonate, turn out to be molecules with higher levels of evidence implicated on the reduction of the main osteoporotic fractures, in particular the reduction of vertebral and femoral fractures. The 10 years long-term extension studies, in particular those that have seen the employment of alendronate, found a positive outcome regarding densitometry data and a favorable trend in antifracture effectiveness. Ibandronate is another amino-bisphosphonate which was recently validated as an effective drug for the treatment of osteoporosis with its documented ability to meaningfully reduce vertebral fractures. Also ranelate of strontium, a drug that seems to explain its own result in a different way from the other antiresorptive bone agents, constitutes another valid alternative in the treatment of this pathology. Both of these molecules however, need further studies in order to estimate their antifracture effectiveness in the long term, particularly those related to femoral fractures. Teriparatide and the entire molecule paratohormone are usually not prescribed for its high cost in treatment and because, typically, patients with high-risk level fractures that are already affected, produce more vertebral fractures from moderate to severe intensity.


Sujet(s)
Agents de maintien de la densité osseuse/usage thérapeutique , Fractures osseuses/étiologie , Fractures osseuses/prévention et contrôle , Ostéoporose post-ménopausique/complications , Alendronate/usage thérapeutique , Résorption osseuse/prévention et contrôle , Calcitonine/usage thérapeutique , Acide clodronique/usage thérapeutique , Diphosphonates/usage thérapeutique , Acide étidronique/analogues et dérivés , Acide étidronique/usage thérapeutique , Médecine factuelle , Femelle , Humains , Acide ibandronique , Composés organométalliques/usage thérapeutique , Acide risédronique , Modulateurs sélectifs des récepteurs des oestrogènes/usage thérapeutique , Tériparatide/usage thérapeutique , Thiophènes/usage thérapeutique , Vitamine D/usage thérapeutique
7.
Chemosphere ; 69(7): 1055-63, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17544480

RÉSUMÉ

Multivariate factor analytical techniques are widely used for the approximation, in terms of a linear combination of factors, of multivariate experimental data. The chemical composition of soil samples are multivariate in nature and provide datasets suitable for the application of these statistical techniques. Recent developments of multivariate factor analytical techniques have led to the approach of Positive Matrix Factorization (PMF), a weighted least squares fit of a data matrix in which the weights are determined depending on the error estimates of each individual data value. This approach relies on more physically significant assumptions than methods like Principal Components Analysis which is frequently used in the analysis of soil datasets. In this paper we apply PMF to characterise the pollutant source in a set of geographically referenced soil samples taken within a 200 m radius of a site characterised by a high concentration of heavy metals. Each sample has been analysed for major and minor elements (using wavelength-dispersive X-ray fluorescence spectrometry), carbon, hydrogen and nitrogen (using a CHN elemental analyzer) and mercury (using cold-vapour atomic absorption spectrometry). Analysis of the soils using PMF resulted in a successful partitioning of variances into sources related to background soil geochemistry, organic influences and those associated with the contamination. Combining these results with a geostatistical approach successfully demarcated the main source of the combined organic and heavy metal contamination.


Sujet(s)
Surveillance de l'environnement/méthodes , Polluants du sol/analyse , Sol/analyse , Italie , Métaux/analyse , Modèles théoriques , Analyse multifactorielle , Diffraction des rayons X
8.
Surg Endosc ; 21(1): 41-7, 2007 Jan.
Article de Anglais | MEDLINE | ID: mdl-17111279

RÉSUMÉ

BACKGROUND: No unanimous consensus has been reached as to the need for routine laparoscopic cholecystectomy (LC) after endoscopic sphincterotomy (ES) for choledocholithiasis in very elderly patients, who are considered as high-risk subjects for surgery. METHODS: From 1991 through 1997, 170 patients were referred to undergo preoperative ES and routine LC for common bile duct (CBD) stones. The results for 27 patients (age 80 years or older) were compared with those achieved for younger patients. Successively, in a retrospective case-control study, the results for the selected patients were compared with those for 27 very elderly patients who underwent endoscopic retrograde cholangiopancreatography (ERCP), but did not receive LC. The mean follow-up period was 126 months. RESULTS: Octogenarians showed longer surgery time (79 vs 51 min) and postoperative hospital stay (2.8 vs 1.2 days), as well as more early low-grade complications (15% vs 3%), whereas there were no differences in conversion rate or serious complications. Recurrent symptoms or complications developed in 48% of octogenarians not undergoing routine LC, and 30% finally needed surgery. One patient in the control group died after emergency cholecystectomy for acute cholecystitis. The results of surgery were significantly poorer for the control group. CONCLUSIONS: Although a "wait-and-see" policy allowed two-thirds of LCs to be avoided in octogenarians, biliary-related events developed for every second patient, often requiring delayed surgery, with poorer results. Sequential treatment (ES followed by elective LC) is a safe procedure for octogenarians, and should be considered as a standard, definitive treatment for cholecystocholedocholithiasis even after the age of 80 years.


Sujet(s)
Cholécystectomie laparoscopique , Lithiase cholédocienne/chirurgie , Sphinctérotomie endoscopique , Sujet âgé , Sujet âgé de 80 ans ou plus , Études cas-témoins , Cause de décès , Cholangiopancréatographie rétrograde endoscopique , Cholécystectomie laparoscopique/effets indésirables , Lithiase cholédocienne/imagerie diagnostique , Lithiase cholédocienne/mortalité , Services des urgences médicales , Femelle , Études de suivi , Humains , Durée du séjour , Mâle , Adulte d'âge moyen , Récidive , Réintervention , Études rétrospectives , Appréciation des risques , Facteurs temps
9.
Dis Esophagus ; 19(2): 88-93, 2006.
Article de Anglais | MEDLINE | ID: mdl-16643176

RÉSUMÉ

Patient-reported outcomes have grown in importance in assessing the value of a variety of treatments. One of the methods of assessing patient-reported outcomes is qualitative analysis. The purpose of this study was to assess if qualitative analysis can be used to assess patient expectations for antireflux surgery in different nationalities. Patients referred for antireflux surgery (ARS) in the US, Austria and Italy were prospectively studied. Preoperatively, they were asked: (i) 'How do you expect the surgery to affect your symptoms?'; (ii) 'What do you expect the possible complications or side effects to be?' These patients then underwent open or laparoscopic antireflux surgery. At 2-3 months postoperatively, they were asked: (i) 'Are you satisfied with your surgery? If so, why? If not, why not?'; (ii) 'Did your surgery meet your expectations? If not, why not?' Twenty patients in the US, 24 in Austria, and 18 in Italy completed the study. Preoperatively, there were significant differences between the patients in demographics and objective measurements of GERD. Symptomatic relief was the most common expectation. There was variation in question #2, with Austrian and Italian patients more likely to mention conversion and postoperative side effects. Postoperatively, 90% of American, 88% of Austrian, and 89% of Italian patients were satisfied. Causes for dissatisfaction were postoperative complications, symptomatic recurrences, or side effects. Ninety percent of American, 96% of Austrian, and 94% of Italian patients said that their expectations were met. Patients who did not mention the possibility of side effects or complications were more likely to be dissatisfied. Qualitative analysis is a useful tool in assessing patient expectations. Expectations were remarkably similar. Patients who did not mention postoperative adverse events as possibilities preoperatively were more likely to be dissatisfied.


Sujet(s)
Gastroplicature/méthodes , Reflux gastro-oesophagien/chirurgie , Satisfaction des patients , Adulte , Autriche , Femelle , Humains , Italie , Mâle , Adulte d'âge moyen , Études prospectives , Assurance de la qualité des soins de santé , Enquêtes et questionnaires , Résultat thérapeutique , États-Unis
10.
Phytother Res ; 20(7): 573-5, 2006 Jul.
Article de Anglais | MEDLINE | ID: mdl-16619335

RÉSUMÉ

Excessive generation of reactive oxygen species (ROS) by polymorphonuclear leukocytes (PMNL) is involved in the pathology of many inflammatory diseases. Compounds isolated from natural sources with antioxidant activity can be helpful to inhibit and/or modulate the oxidative damage associated with PMNL-derived ROS. The present study investigated the relationship between the chemical structure of five methoxylated flavonoids, isolated from Chromolaena hirsuta and Chromolaena squalida, and their inhibitory activity on ROS generation by opsonized zymosan-stimulated PMNL. The antioxidant efficacy of the studied flavonoids, assessed by luminol-dependent chemiluminescence, was dependent on the position and number of methoxy and hydroxy groups.


Sujet(s)
Chromolaena/composition chimique , Flavonoïdes/composition chimique , Flavonoïdes/pharmacologie , Facteurs immunologiques/pharmacologie , Animaux , Femelle , Facteurs immunologiques/composition chimique , Agranulocytes/effets des médicaments et des substances chimiques , Structure moléculaire , Lapins , Espèces réactives de l'oxygène , Relation structure-activité
11.
Dig Liver Dis ; 38(1): 51-4, 2006 Jan.
Article de Anglais | MEDLINE | ID: mdl-16321581

RÉSUMÉ

Aortoesophageal fistula, secondary to thoracic aortic aneurysm, is an uncommon cause of gastrointestinal bleeding that is uniformly fatal without surgical intervention. Typical symptoms are midthoracic pain and/or dysphagia followed by a usually short, albeit unpredictable, symptom-free interval and by a 'herald' haemorrhage, which is observed in 80% of patients before fatal exsanguinations. Dysphagia is present in 45% of patients, sometimes for several weeks, before the first bleeding occurs. However, dysphagia aortica is rarely considered in the differential diagnosis of dysphagia and lack of awareness, as well as symptom's underevaluation, both contribute to a significant diagnostic and therapeutic delay. We present a case of a 77-year-old woman who died for a bleeding AEF consequent to a thoracic aortic aneurysm and whose main symptom during the past 2 months was dysphagia, which was not taken seriously into consideration by her general practitioner. This case report emphasises that primary care physicians should be alerted to evaluate carefully the alarming symptoms like dysphagia -- especially in elderly patients -- before life threatening complications occur, as they are the ones who could suspect early the diagnosis and make a proper referral.


Sujet(s)
Maladies de l'aorte/complications , Troubles de la déglutition/étiologie , Fistule oesophagienne/complications , Fistule vasculaire/complications , Sujet âgé , Anévrysme de l'aorte thoracique/complications , Troubles de la déglutition/diagnostic , Issue fatale , Femelle , Hémorragie/étiologie , Humains
12.
Bioorg Med Chem Lett ; 15(16): 3713-6, 2005 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-15946843

RÉSUMÉ

Two isomers of the hexahydro-tetraazaacenaphthylene templates (1 and 2) are presented as novel, potent, and selective corticotropin releasing factor-1 (CRF1) receptor antagonists. In this paper, we report the affinity and SAR of a series of compounds, as well as pharmacokinetic characterization of a chosen set. The anxiolitic activity of a selected example (2ba) in the rat pup vocalization model is also presented.


Sujet(s)
Acénaphtène/pharmacologie , Acénaphtène/usage thérapeutique , Anxiété/traitement médicamenteux , Dépression/traitement médicamenteux , Récepteur CRH/antagonistes et inhibiteurs , Acénaphtène/synthèse chimique , Animaux , Modèles animaux de maladie humaine , Évaluation préclinique de médicament , Structure moléculaire , Rats , Rat Wistar , Relation structure-activité
13.
Monaldi Arch Chest Dis ; 61(2): 128-30, 2004.
Article de Anglais | MEDLINE | ID: mdl-15510715

RÉSUMÉ

The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventional therapies has been reported to be complicated by opportunistic infections. We report the case of a 56-yr old female rheumatoid arthritis patient complaining of fever and respiratory symptoms 9 months after commencing Infliximab, who received no ethiologic diagnosis for the six months before admission. Tuberculosis was suspected upon chest radiographic pictures and empirical treatment for miliary tuberculosis instated in the wake of microbiological confirmation. The case typifies the difficulties of diagnosing miliary tuberculosis in the immunocompromised as well as in the immunocompetent patient.


Sujet(s)
Anticorps monoclonaux/effets indésirables , Antirhumatismaux/effets indésirables , Polyarthrite rhumatoïde/traitement médicamenteux , Tuberculose miliaire/diagnostic , Anticorps monoclonaux/usage thérapeutique , Antirhumatismaux/usage thérapeutique , Femelle , Humains , Infliximab , Adulte d'âge moyen , Tomodensitométrie , Test tuberculinique , Tuberculose miliaire/imagerie diagnostique
14.
J Clin Gastroenterol ; 38(8): 710-6, 2004 Sep.
Article de Anglais | MEDLINE | ID: mdl-15319657

RÉSUMÉ

BACKGROUND/AIMS: A delay in recognizing and treating an inflamed gallbladder may increase the risk of a necrotic evolution and represent a critical factor affecting the progression of the inflammatory process. Aim of the study is to assess the therapeutic attitude in patients with histologically proved gangrenous cholecystitis, to find out whether it could play a role in the progression of the inflammatory condition. METHODOLOGY: Twenty-seven patients with gangrenous cholecystitis at histology were compared with a matched-control group with phlegmonous cholecystitis. RESULTS: Age, gender, ASA score, and concomitant diseases did not differ significantly in both groups. WBC was significantly higher (P = 0.026) in patients with gangrene. Ultrasounds were unhelpful in identifying the severity of the disease. Patients with gangrenous gallbladder showed a significantly increased (P = 0.0006) admission delay compared with controls (104.3+/-15.3 hours vs. 59.7+/-7.7 hours). Surgeon's delay, morbidity and mortality were not different in both groups. CONCLUSION: Patient's delay before hospitalization may represent a crucial factor in the progression toward a more severe disease in acute cholecystitis. The time between symptoms onset and hospital admission (and consequently surgery) was significantly longer in patients with gangrenous cholecystitis, further emphasizing the need for an early (if not urgent) surgical treatment in acute cholecystitis, even with mild symptoms.


Sujet(s)
Cholécystite/prévention et contrôle , Sujet âgé , Cholécystite/anatomopathologie , Cholécystite/chirurgie , Femelle , Gangrène , Humains , Mâle , Adulte d'âge moyen , Soins préopératoires , Facteurs temps
15.
Phytother Res ; 18(3): 250-4, 2004 Mar.
Article de Anglais | MEDLINE | ID: mdl-15103676

RÉSUMÉ

Phytochemical study of Chromolaena hirsuta (Hook. & Arn.) R. King & H. Robinson crude extract (collected in Furnas, MG-Brasil) produced fifteen flavonoids, two triterpenes and five steroids. IR, UV,(1)H and (13)C NMR spectroscopy and GC analysis were used for the identification of these compounds. The dichloromethanic and ethanolic crude extracts (flowers and leaves) and six flavonoids isolated from this specie have been assayed for antiprotozoal activity against tripomastigote forms of Trypanosoma cruzi and promastigote forms of Leishmania amazonensis. The crude extracts significantly reduced the viability of T. cruzi and Leishmania amazonensis, and the six flavonoids showed considerable antiproliferative effect of development of two parasites evaluated. This is the fi rst report of antiprotozoal activity of extracts of C. hirsuta.


Sujet(s)
Antiprotozoaires/pharmacologie , Chromolaena , Flavonoïdes/pharmacologie , Leishmania/effets des médicaments et des substances chimiques , Phytothérapie , Extraits de plantes/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Animaux , Antiprotozoaires/administration et posologie , Antiprotozoaires/usage thérapeutique , Flavonoïdes/administration et posologie , Flavonoïdes/usage thérapeutique , Fleurs , Tests de sensibilité parasitaire , Extraits de plantes/administration et posologie , Extraits de plantes/usage thérapeutique , Feuilles de plante
16.
Surg Endosc ; 18(2): 266-71, 2004 Feb.
Article de Anglais | MEDLINE | ID: mdl-14691693

RÉSUMÉ

BACKGROUND: Although the degree of surgical experience clearly affects early outcome of laparoscopic antireflux surgery, its influence on long-term results has not been fully evaluated. The aim of this study was to verify whether the initial experience in laparoscopic antireflux surgery could also influence the late clinical outcome. METHODS: Clinical and endoscopic findings, together with quality of life, of the first 25 patients successfully submitted to laparoscopic fundoplication were compared with those of 25 matched controls operated on later. RESULTS: At more than 2 years', follow-up, reflux symptoms, endoscopic findings, use of antisecretory drugs, side effects, and quality of life were not significantly different in both groups, despite a high occurrence of major anatomical failures (three vs one) in the first set of patients. CONCLUSION: The late clinical outcome of patients with gastroesophageal disease operated on during the learning phase or after gaining experience is not different, provided the surgeon is adequately trained in laparoscopic surgery.


Sujet(s)
Gastroplicature/enseignement et éducation , Reflux gastro-oesophagien/chirurgie , Laparoscopie , Adulte , Antiacides gastriques/usage thérapeutique , Association thérapeutique , Femelle , Études de suivi , Gastroplicature/méthodes , Gastroplicature/statistiques et données numériques , Reflux gastro-oesophagien/traitement médicamenteux , Humains , Laparoscopie/statistiques et données numériques , Apprentissage , Mâle , Adulte d'âge moyen , Complications postopératoires , Inhibiteurs de la pompe à protons , Qualité de vie , Études rétrospectives , Facteurs temps , Résultat thérapeutique
17.
Dig Liver Dis ; 35(11): 818-38, 2003 Nov.
Article de Anglais | MEDLINE | ID: mdl-14674675

RÉSUMÉ

Gastro-oesophageal reflux disease represents an extremely common disorder which has a substantial impact on patients' quality of life and use of health care resources. Gastro-oesophageal reflux disease is a chronic relapsing disease for which a lifelong solution is needed. Until now the two competing therapeutic modalities have been the medical and surgical therapies. Quite recently a third option has become available. A number of endoscopic anti-reflux procedures have been described, with the common goal of creating an anti-reflux barrier, thus obviating long-term proton pump inhibitors and the cost and potential risk of laparoscopic Nissen fundoplication. In this review the different techniques are thoroughly examined and the results are critically evaluated, giving special emphasis to efficacy, safety and durability of these new anti-reflux procedures. Available data show that these anti-reflux techniques produce significant improvement in gastro-oesophageal reflux disease symptomatology and quality of life as well as reduce the use of anti-reflux medication, without causing serious morbidity or mortality. However, the majority of these techniques have failed to adequately control oesophageal acid reflux. Endoscopic anti-reflux therapies therefore sound very attractive-being less invasive than surgery-and show a significant promise, but are still in the early stages of assessment. Large-scale randomized multi-centre trials comparing control groups with sham procedures are essential to confirm their efficacy. Further studies are also necessary to determine what modifications these techniques require in order to produce maximum clinical efficacy and durability. However, considering that current therapies (both medical and surgical) of gastro-oesophageal reflux disease are highly effective, the need for such new endoscopic modalities may be questionable. Moreover, appropriate trials in dedicated centres should be carried out to assure that the enthusiasm commonly associated with new technology is justified and can be generalized to open-access endoscopists.


Sujet(s)
Endoscopie digestive/méthodes , Reflux gastro-oesophagien/chirurgie , Matériaux biocompatibles/usage thérapeutique , Endoscopie digestive/effets indésirables , Humains , /usage thérapeutique , Sélection de patients , Poly(méthacrylate de méthyle)/usage thérapeutique , Polyvinyles/usage thérapeutique , Prothèses et implants , Techniques de suture
18.
Minerva Chir ; 58(3): 405-8, 2003 Jun.
Article de Anglais | MEDLINE | ID: mdl-12955065

RÉSUMÉ

We report a patient in whom heterotopic pancreatic tissue was found within the ampulla and treated by ampullectomy. Only 16 cases of pancreatic tissue located at the ampulla of Vater have been reported in the literature and pancreaticoduodenectomy has been performed in more than half the cases because malignancy was suspected preoperatively, reflecting a rather aggressive surgical attitude. An accurate preoperative evaluation thus appears decisive to avoid unnecessary radical surgery. Endoscopic treatment of ampullary tumors is emerging as a viable alternative to surgical treatment. Local surgical excision is a reasonable option to endoscopic treatment. The possibility of heterotopic pancreatic tissue, though rare, should be included in the differential diagnosis of papillary tumors. Histologic confirmation (frozen or delayed) is mandatory before attempting such major surgery.


Sujet(s)
Ampoule hépatopancréatique , Choristome , Maladies du cholédoque , Pancréas , Sujet âgé , Choristome/diagnostic , Choristome/chirurgie , Maladies du cholédoque/diagnostic , Maladies du cholédoque/chirurgie , Femelle , Humains , Pancréas/chirurgie
19.
Surg Endosc ; 16(11): 1555-60, 2002 Nov.
Article de Anglais | MEDLINE | ID: mdl-12072998

RÉSUMÉ

BACKGROUND: Health-related quality of life (HRQL) is significantly affected by gastroesophageal reflux disease (GERD), and its evaluation is emerging as a factor important to select treatment options for GERD. Antireflux laparoscopic surgery improves HRQL. The aim of this study was to compare the preoperative and medium-term postoperative HRQL in patients submitted to laparoscopic fundoplication during the initial experience to verify its possible influence on HRQL outcomes. METHODS: Clinical assessment, endoscopy, and a previously validated HRQL index were performed before and 2 years after surgery in 32 patients who underwent at the beginning of our experience. RESULTS: The esophageal mucosa returned to normal 2 years after laparoscopic fundoplication in 81% of the patients. Heartburn was absent or occasional in 93%, and 65% were free of antisecretory drugs. All postoperative HRQL items were significantly improved (p <0.0001), with the postoperative curve of HRQL scores superposable to those of healthy Italian subjects (Italian normative sample). CONCLUSIONS: The initial phase of learning does not affect the improvement of HRQL observed after laparoscopic antireflux surgery, which is consistent with durable relief of symptoms and endoscopic healing. Evaluation of HRQL should be added to, and probably could replace in most cases, the objective postoperative testing.


Sujet(s)
Gastroplicature/méthodes , Reflux gastro-oesophagien/chirurgie , État de santé , Laparoscopie/méthodes , Qualité de vie , Adulte , Sujet âgé , Antiacides gastriques/usage thérapeutique , Troubles de la déglutition/étiologie , Femelle , Études de suivi , Gastroplicature/effets indésirables , Reflux gastro-oesophagien/complications , Reflux gastro-oesophagien/traitement médicamenteux , Pyrosis/traitement médicamenteux , Pyrosis/étiologie , Humains , Laparoscopie/effets indésirables , Mâle , Adulte d'âge moyen , Complications postopératoires/étiologie , Soins préopératoires , Enquêtes et questionnaires , Facteurs temps , Résultat thérapeutique
20.
Surg Endosc ; 16(5): 871, 2002 May.
Article de Anglais | MEDLINE | ID: mdl-11997848

RÉSUMÉ

We present a patient with a hamartoma of the spleen. The case was thought to be a good indication for a hand-assisted laparoscopic approach and treatment was successful. Until now, only one case of a laparoscopic removal of a splenic hamartoma has been reported. Focal lesions of the spleen should be removed intact to allow a complete histological examination and to avoid peritoneal dissemination in case of malignancy. In these patients, the hand-assisted approach makes possible the removal of an unminced organ and has the advantage of being a purely laparoscopic technique. It should thus be considered the method of choice for surgical treatment.


Sujet(s)
Hamartomes/chirurgie , Laparoscopie/méthodes , Splénectomie/méthodes , Maladies de la rate/chirurgie , Femelle , Humains , Adulte d'âge moyen
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE